Clinical Trial Update: Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute Schizophrenic [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial assesses the efficacy and safety of Seroquel (quetiapine fumarate) as monotherapy for acute schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED